
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Germany), Germany, covering academic research published from 2003 to 2025. Read More.
Open Access Percentage
53%
Total
Publications
152
Total Open
Publications
81
Total
Citations
3.8K
Open Access
Percentage
53%
Total
Publications
152
Total Open
Publications
81
Total
Citations
3.8K
Breakdown
Publisher Open
20%
Both
28%
Other Platform Open
5%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
21
Hybrid 37%
27
No Guarantees 34%
25
Other Platform Open
Domain 73%
36
Institution 51%
25
Other Internet 12%
6
Public 6%
3
Preprint 4%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 36 |
doaj.org OAI-PMH Repository | Institution | 12 |
DOI | Other Internet | 4 |
Unknown Repository | Other Internet | 3 |
University of Bristol | Institution | 3 |
LA Referencia | Institution | 3 |
Figshare | Public | 3 |
Technical University of Munich | Institution | 2 |
Maastricht University | Institution | 2 |
arXiv | Preprint | 2 |